Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

DermTech Q3 2023 Gaap EPS $(0.57) Beats $(0.76) Estimate, Sales $3.92M Beat $3.90M Estimate

Author: Benzinga Newsdesk | November 02, 2023 04:06pm
DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.76) by 25 percent. This is a 40.63 percent increase over losses of $(0.96) per share from the same period last year. The company reported quarterly sales of $3.92 million which beat the analyst consensus estimate of $3.90 million by 0.38 percent. This is a 9.57 percent increase over sales of $3.57 million the same period last year.

Posted In: DMTK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist